Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SOMATROPIN vs SORAFENIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

SOMATROPIN vs SORAFENIB: Safety Overview

Metric SOMATROPIN SORAFENIB
Total FAERS Reports 68,384 10,908
Deaths Reported 1,350 2,489
Death Rate 2.0% 22.8%
Hospitalizations 4,957 3,547
Average Patient Age 18.2 yrs 61.1 yrs
% Female Patients 39.8% 29.5%
FDA Approval Date N/A Apr 12, 2023
Manufacturer Genentech, Inc. Upsher-Smith Laboratories, LLC
Route SUBCUTANEOUS ORAL
Marketing Status Discontinued Prescription